Vir Biotechnology (VIR) Shares Outstanding (2018 - 2026)

Vir Biotechnology has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $161.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 16.78% year-over-year to $161.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.2 million (up 16.78% YoY) and the FY2025 annual result came in at $139.5 million, up 1.84% from the prior year.
• Shares Outstanding (Entity) advanced to $161.2 million in Q1 2026 per VIR's latest filing, from $139.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $161.2 million in Q1 2026 and troughed at $132.4 million in Q1 2022.
• A 5-year average of $137.1 million and a median of $135.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) advanced 1.11% in 2023, then rose 16.78% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $133.2 million in 2022, then gained by 1.16% to $134.8 million in 2023, then rose by 1.62% to $137.0 million in 2024, then rose by 1.84% to $139.5 million in 2025, then rose by 15.6% to $161.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $161.2 million, $139.5 million, and $139.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.